Publications by authors named "Craig Innes"

Claim this Profile
N
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.
Nonhlanhla N Mkhize, Bo Zhang, Caroline Brackett, Peter James Elyanu, Asa Tapley, Craig Innes, Steve Innes

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Biomarkers of Asymptomatic and Symptomatic Tuberculosis.
Denis Awany, Dominique T Ariefdien, Simon C Mendelsohn, Virginie Rozot, Humphrey Mulenga, Craig Innes

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial.
Álvaro H Borges, Marisa Russell, Dereck Tait, Thomas J Scriba, Elisa Nemes, Craig Innes

Lancet Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines.
Cassie G Ackerley, Srilatha Edupuganti, Chenchen Yu, Alison C Roxby, Kelly E Seaton, Craig Innes

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study.
Nigel Garrett, Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Craig Innes, Steve Innes

EClinicalMedicine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.
Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Azwidhwi Takalani, Kubashni Woeber, Craig Innes, Steve Innes

PLOS Glob Public Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.
Vimla Naicker, Fatima Laher, Linda-Gail Bekker, Kelly E Seaton, Mary Allen, Craig Innes

PLOS Glob Public Health· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702.
Rachel Chihana, Jia Jin Kee, Zoe Moodie, Yunda Huang, Holly Janes, Craig Innes

Vaccine· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.
Ying Huang, Shomoita Alam, Erica Andersen-Nissen, Lindsay N Carpp, One B Dintwe, Craig Innes

Viruses· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
Zoe Moodie, One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Craig Innes

J Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis.
Humphrey Mulenga, Munyaradzi Musvosvi, Simon C Mendelsohn, Adam Penn-Nicholson, Stanley Kimbung Mbandi, Craig Innes

Am J Respir Crit Care Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study.
Simon C Mendelsohn, Andrew Fiore-Gartland, Adam Penn-Nicholson, Humphrey Mulenga, Stanley Kimbung Mbandi, Craig Innes

Lancet Glob Health· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.
Thomas J Scriba, Andrew Fiore-Gartland, Adam Penn-Nicholson, Humphrey Mulenga, Stanley Kimbung Mbandi, Craig Innes

Lancet Infect Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.
Erica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, Lindsay N Carpp, Anneta F Naidoo, Craig Innes

PLoS Pathog· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
Glenda E Gray, Linda-Gail Bekker, Fatima Laher, Mookho Malahleha, Mary Allen, Craig Innes

N Engl J Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.
Mina C Hosseinipour, Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hutter

Clin Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
Zoe Moodie, Stephen R Walsh, Fatima Laher, Lucas Maganga, Michael E Herce, Craig Innes

PLoS Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans.
Lue Ping Zhao, Andrew Fiore-Gartland, Lindsay N Carpp, Kristen W Cohen, Nadine Rouphael, Craig Innes

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
Fatima Laher, Zoe Moodie, Kristen W Cohen, Nicole Grunenberg, Linda-Gail Bekker, Craig Innes

PLoS Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.
Glenda E Gray, Ying Huang, Nicole Grunenberg, Fatima Laher, Surita Roux, Craig Innes

Sci Transl Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
Linda-Gail Bekker, Zoe Moodie, Nicole Grunenberg, Fatima Laher, Georgia D Tomaras, Craig Innes

Lancet HIV· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
Zoe Moodie, Barbara Metch, Linda-Gail Bekker, Gavin Churchyard, Maphoshane Nchabeleng, Craig Innes

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Lindsey R Baden, Etienne Karita, Gaudensia Mutua, Linda-Gail Bekker, Glenda Gray, Craig Innes

Ann Intern Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa.
Erica Maxine Lazarus, Kennedy Otwombe, Tania Adonis, Elaine Sebastian, Glenda Gray, Craig Innes

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
Glenda E Gray, Zoe Moodie, Barbara Metch, Peter B Gilbert, Linda-Gail Bekker, Craig Innes

Lancet Infect Dis· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis